Cancer Screening During the Coronavirus Disease-2019 Pandemic: A Perspective From the National Cancer Institute's PROSPR Consortium.

Szczegóły

Tytuł:: Cancer Screening During the Coronavirus Disease-2019 Pandemic: A Perspective From the National Cancer Institute's PROSPR Consortium.
Autorzy:: Corley DA; Division of Research, Kaiser Permanente Northern California, Oakland, California.
Sedki M; Division of Research, Kaiser Permanente Northern California, Oakland, California.
Ritzwoller DP; Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado.
Greenlee RT; Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin.
Neslund-Dudas C; Department of Public Health Sciences, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, Michigan.
Rendle KA; Department of Family Medicine and Community Health, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Honda SA; Department of Pathology, Kaiser Permanente Hawaii, Honolulu, Hawaii.
Schottinger JE; Department of Hematology and Oncology, Kaiser Permanente Southern California, Oakland, California.
Udaltsova N; Division of Research, Kaiser Permanente Northern California, Oakland, California.
Vachani A; Division of Pulmonology, Allergy and Critical Care, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Kobrin S; National Cancer Institute, Bethesda, Maryland.
Li CI; Fred Hutchinson Cancer Research Center, Seattle, Washington.
Haas JS; Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Corporate Authors:: National Cancer Institute’s PROSPR Consortium
Źródło:: Gastroenterology [Gastroenterology] 2021 Mar; Vol. 160 (4), pp. 999-1002. Date of Electronic Publication: 2020 Oct 21.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
Język:: English
Imprint Name(s):: Publication: Philadelphia, PA : W.B. Saunders
Original Publication: Baltimore.
MeSH Terms:: SARS-CoV-2*
COVID-19/*epidemiology
Early Detection of Cancer/*statistics & numerical data
Early Detection of Cancer/economics ; Health Status Disparities ; Humans ; National Cancer Institute (U.S.) ; Occult Blood ; United States
References:: PLoS Med. 2020 Sep 22;17(9):e1003379. (PMID: 32960880)
JAMA Netw Open. 2020 Aug 03;3(8):e2018039. (PMID: 32809033)
N Engl J Med. 2020 Aug 13;383(7):691-693. (PMID: 32427432)
Gastroenterology. 2020 Aug;159(2):739-758.e4. (PMID: 32247018)
Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):158-164. (PMID: 29150480)
JAMA Netw Open. 2020 Aug 3;3(8):e2017267. (PMID: 32749465)
Grant Information:: R01 CA213645 United States CA NCI NIH HHS; U24 CA221936 United States CA NCI NIH HHS; UM1 CA221939 United States CA NCI NIH HHS; UM1 CA222035 United States CA NCI NIH HHS
Entry Date(s):: Date Created: 20201023 Date Completed: 20210323 Latest Revision: 20221110
Update Code:: 20240105
PubMed Central ID:: PMC7575503
DOI:: 10.1053/j.gastro.2020.10.030
PMID:: 33096099
: Czasopismo naukowe

Informacja